General Features of Autoimmune Disease

The Autoimmune Diseases, Fourth Edition

Volumn , Issue , 2006, Pages 25-36

  Davidson, Anne ^a   Diamond, Betty ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 49649102491     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012595961-2/50006-8     Document Type: Chapter

References (141)

1. L.J. Albert and R.D. Inman (1999) Molecular mimicry and autoimmunity. N. Engl. J. Med. 341 2068-2074.
2. E.C. Baechler, F.M. Batliwalla, G. Karypis, P.M. Gaffney, W.A. Ortmann, K.J. Espe, K.B. Shark, W.J. Grande, K.M. Hughes, V. Kapur, P.K. Gregersen and T.W. Behrens (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100 2610-2615.
3. J. Banchereau and R.M. Steinman (1998) Dendritic cells and the control of immunity. Nature 392 245-252.
4. S. Beck and J. Trowsdale (2000) The human major histocompatability complex: lessons from the DNA sequence. Annu. Rev. Genomics Hum. Genet. 1 117-137.
5. L. Bennett, A.K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau and V. Pascual (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197 711-723.
6. A. Billiau (1996) Interferon-gamma in autoimmunity. Cytokine Growth Factor Rev. 7 25-34.
7. D.J. Birmingham, B.H. Rovin, C.Y. Yu and L.A. Hebert (2001) Of mice and men: the relevance of the mouse to the study of human SLE. Immunol. Res. 24 211-224.
8. F. Bischof, M. Hofmann, T.N. Schumacher, F.A. Vyth-Dreese, R. Weissert, H. Schild, A.M. Kruisbeek and A. Melms (2004) Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers. J. Immunol. 172 2878-2884.
9. G.A. Bishop and B.S. Hostager (2003) The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev. 14 297-309.
10. G.A. Bishop, S.A. Haxhinasto, L.L. Stunz and B.S. Hostager (2003) Antigen-specific B-lymphocyte activation. Crit. Rev. Immunol. 23 149-197.
11. L.K. Bockenstedt, R.J. Gee and M.J. Mamula (1995) Self-peptides in the initiation of lupus autoimmunity. J. Immunol. 154 3516-3524.
12. U. Bommhardt, M. Beyer, T. Hunig and H.M. Reichardt (2004) Molecular and cellular mechanisms of T cell development. Cell. Mol. Life. Sci. 61 263-280.
13. A. Boonstra, C. Asselin-Paturel, M. Gilliet, C. Crain, G. Trinchieri, Y.J. Liu and A. O'Garra (2003) Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential Toll-like receptor ligation. J. Exp. Med. 197 101-109.
14. M. Brigl and M.B. Brenner (2004) CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22 817-890.
15. T. Brunner, C. Wasem, R. Torgler, I. Cima, S. Jakob and N. Corazza (2003) Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology. Semin. Immunol. 15 167-176.
16. D.J. Campbell, C.H. Kim and E.C. Butcher (2001) Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat. Immunol. 2 876-881.
17. M.T. Cantorna (2000) Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc. Soc. Exp. Biol. Med. 223 230-233.
18. L. Chen (2004) Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4 336-347.
19. R. Clynes, C. Dumitru and J.V. Ravetch (1998) Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279 1052-1054.
20. R. Cortesini, J. LeMaoult, R. Ciubotariu and N.S. Cortesini (2001) CD8+CD28-T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity. Immunol. Rev. 182 201-206.
21. F. Cottrez and H. Groux (2004) Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells. Transplantation 77 12-15.
22. A. Craxton, D. Magaletti, E.J. Ryan and E.A. Clark (2003) Macrophage- and dendritic-cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101 4464-4471.
23. M.K. Crow (2004) Costimulatory molecules and T-cell-B-cell interactions. Rheum. Dis. Clin. North Am. 30 175-191.
24. M.K. Crow (2004) Costimulatory molecules and T-cell-B-cell interactions. Rheum. Dis. Clin. North Am. 30 vii-viii
25. M.W. Cunningham (2003) Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease. Front. Biosci. 8 533-543.
26. A. Davidson and B. Diamond (2001) Autoimmune diseases. N. Engl. J. Med. 345 340-350.
27. A. Davidson, K. Konstantinov and B. Diamond (2002) J. Smolen, P. Lipsky (Eds) Biological Therapy in Rheumatology London: Martin Dunitz
28. D. D'Cruz (2000) Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol. Lett. 112–113 421-432.
29. M. Debandt, O. Vittecoq, V. Descamps, X. Le Loet and O. Meyer (2003) Anti-TNF-alpha-induced systemic lupus syndrome. Clin. Rheumatol. 22 56-61.
30. T. Defrance, M. Casamayor-Palleja and P.H. Krammer (2002) The life and death of a B cell. Adv. Cancer Res. 86 195-225.
31. I. Djilali-Saiah, V. Benini, S. Daniel, R. Assan, J.F. Bach and S. Caillat-Zucman (1996) Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex. Tissue Antigens 48 87-92.
32. C. Dong and R.A. Flavell (2001) Th1 and Th2 cells. Curr. Opin. Hematol. 8 47-51.
33. G. Filaci and N. Suciu-Foca (2002) CD8+ T suppressor cells are back to the game: are they players in autoimmunity? Autoimmun. Rev. 1 279-283.
34. T.A. Fleisher, S.E. Straus and J.J. Bleesing (2001) A genetic disorder of lymphocyte apoptosis involving the Fas pathway: the autoimmune lymphoproliferative syndrome. Curr. Allergy Asthma Rep. 1 534-540.
35. J.D. Fontenot and A.Y. Rudensky (2004) Molecular aspects of regulatory T cell development. Semin. Immunol. 16 73-80.
36. G.J. Fournie, M. Mas, B. Cautain, M. Savignac, J.F. Subra, L. Pelletier, A. Saoudi, D. Lagrange, M. Calise and P. Druet (2001) Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals. J. Autoimmun. 16 319-326.
37. J.A. Gebe, E. Swanson and W.W. Kwok (2002) HLA class II peptide-binding and autoimmunity. Tissue Antigens 59 78-87.
38. T.B. Geijtenbeek, S.J. Van Vliet, A. Engering, B.A. 't Hart and Y. Van Kooyk (2004) Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 22 33-54.
39. M. Gellert (2002) V(D)J recombination: RAG proteins, repair factors, and regulation. Annu. Rev. Biochem. 71 101-132.
40. J. George, Y. Levy and Y. Shoenfeld (1997) Smoking and immunity: an additional player in the mosaic of autoimmunity. Scand. J. Immunol. 45 1-6.
41. K. Ghoreschi and M. Rocken (2004) Immune deviation strategies in the therapy of psoriasis. Curr. Drug. Targets Inflamm. Allergy 3 193-198.
42. D. Gomez, P.A. Correa, L.M. Gomez, J. Cadena, J.F. Molina and J.M. Anaya (2004) Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective? Semin. Arthritis Rheum. 33 404-413.
43. J.D. Gorman, R.F. Lum, J.J. Chen, M.E. Suarez-Almazor, G. Thomson and L.A. Criswell (2004) Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum. 50 400-412.
44. F. Granucci, I. Zanoni, S. Feau, G. Capuano and P. Ricciardi-Castagnoli (2004) The regulatory role of dendritic cells in the immune response. Int. Arch. Allergy Immunol. 134 179-185.
45. P.K. Gregersen (2003) Teasing apart the complex genetics of human autoimmunity: lessons from rheumatoid arthritis. Clin. Immunol. 107 1-9.
46. C.M. Grimaldi, L. Hill, X. Xu, E. Peeva and B. Diamond (2005) Hormonal modulation of B cell development and repertoire selection. Mol. Immunol. 42 811-820.
47. T. Grodzicky and K.B. Elkon (2002) Apoptosis: a case where too much or too little can lead to autoimmunity. Mt. Sinai J. Med. 69 208-219.
48. U. Grohmann and P. Puccetti (2002) The immunosuppressive activity of proinflammatory cytokines in experimental models: potential for therapeutic intervention in autoimmunity. Curr. Drug Targets Inflamm. Allergy 1 77-87.
49. Z. Grossman, B. Min, M. Meier-Schellersheim and W.E. Paul (2004) Concomitant regulation of T-cell activation and homeostasis. Nat. Rev. Immunol. 4 387-395.
50. H. Gu, D. Tarlinton, W. Muller, K. Rajewsky and I. Forster (1991) Most peripheral B cells in mice are ligand selected. J. Exp. Med. 173 1357-1371.
51. L. Guilherme and J. Kalil (2004) Rheumatic fever: from sore throat to autoimmune heart lesions. Int. Arch. Allergy Immunol. 134 56-64.
52. H. Hackstein and A.W. Thomson (2004) Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4 24-34.
53. A. Hanninen, E. Hamilton-Williams and C. Kurts (2003) Development of new strategies to prevent type 1 diabetes: the role of animal models. Ann. Med. 35 546-563.
54. R.D. Henderson, C.J. Bain and M.P. Pender (2000) The occurrence of autoimmune diseases in patients with multiple sclerosis and their families. J. Clin. Neurosci. 7 434-437.
55. N. Hill and N. Sarvetnick (2002) Cytokines: promoters and dampeners of autoimmunity. Curr. Opin. Immunol. 14 791-797.
56. M.S. Horwitz, A. Ilic, C. Fine, E. Rodriguez and N. Sarvetnick (2002) Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J. Clin. Invest. 109 79-87.
57. C.D. Howell (2002) Animal models of autoimmunity. Clin. Liver Dis. 6 487-495.
58. D.L. Jacobson, S.J. Gange, N.R. Rose and N.M. Graham (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84 223-243.
59. J.A. James, B.R. Neas, K.L. Moser, T. Hall, G.R. Bruner, A.L. Sestak and J.B. Harley (2001) Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 44 1122-1126.
60. S.J. Khoury and M.H. Sayegh (2004) The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 20 529-538.
61. M. Knip and H.K. Akerblom (1999) Environmental factors in the pathogenesis of type 1 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 107(Suppl 3), 93-100.
62. W. Kuon and J. Sieper (2003) Identification of HLA-B27-restricted peptides in reactive arthritis and other spondyloarthropathies: computer algorithms and fluorescent activated cell sorting analysis as tools for hunting of HLA-B27-restricted chlamydial and autologous crossreactive peptides involved in reactive arthritis and ankylosing spondylitis. Rheum. Dis. Clin. North Am. 29 595-611.
63. S. Kuwabara (2004) Guillain-Barré syndrome: epidemiology, pathophysiology and management. Drugs 64 597-610.
64. W.K. Lam-Tse, A. Lernmark and H.A. Drexhage (2002) Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity? Springer Semin. Immunopathol. 24 297-321.
65. J. Lang and D. Bellgrau (2002) A T-cell functional phenotype common among autoimmune-prone rodent strains. Scand. J. Immunol. 55 546-559.
66. E. Leadbetter, I.R. Rifkin, A.M. Hohlbaum, B.C. Beaudette, M.J. Shlomchik and A. Marshak-Rothstein (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416 603-607.
67. J.J. Letterio and A.B. Roberts (1998) Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16 137-161.
68. Z. Li, C.J. Woo, M.D. Iglesias-Ussel, D. Ronai and M.D. Scharff (2004) The generation of antibody diversity through somatic hypermutation and class switch recombination. Genes Dev. 18 1-11.
69. L. Liao, R. Sindhwani, M. Rojkind, S. Factor, L. Leinwand and B. Diamond (1995) Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J. Exp. Med. 181 1123-1131.
70. S.N. Liossis and M. Zouali (2004) B lymphocyte selection and survival in systemic lupus. Int. Arch. Allergy Immunol. 133 72-83.
71. P.E. Lipsky (2001) Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat. Immunol. 2 764-766.
72. C.C. Liu, J.S. Navratil, J.M. Sabatine and J.M. Ahearn (2004) Apoptosis, complement and systemic lupus erythematosus: a mechanistic view. Curr. Dir. Autoimmun. 7 49-86.
73. H.R. Liu, R.R. Zhao, X.Y. Jiao, Y.Y. Wang and M. Fu (2002) Relationship of myocardial remodeling to the genesis of serum autoantibodies to cardiac beta(1)-adrenoceptors and muscarinic type 2 acetylcholine receptors in rats. J. Am. Coll. Cardiol. 39 1866-1873.
74. M. Li-Weber and P.H. Krammer (2003) Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system. Semin. Immunol. 15 145-157.
75. T. Lovgren, M.L. Eloranta, U. Bave, G.V. Alm and L. Ronnblom (2004) Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 50 1861-1872.
76. I. MacLennan and C. Vinuesa (2002) Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity 17 235-238.
77. E. Melanitou, P. Fain and G.S. Eisenbarth (2003) Genetics of type 1A (immune mediated) diabetes. J. Autoimmun. 21 93-98.
78. M. Milani, N. Ostlie, W. Wang and B.M. Conti-Fine (2003) T cells and cytokines in the pathogenesis of acquired myasthenia gravis. Ann. N. Y. Acad. Sci. 998 284-307.
79. S. Mocellin, F. Marincola, C.R. Rossi, D. Nitti and M. Lise (2004) The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine Growth Factor Rev. 15 61-76.
80. P.A. Monach, C. Benoist and D. Mathis (2004) The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease. Adv. Immunol. 82 217-248.
81. J.G. Monroe, G. Bannish, E.M. Fuentes-Panana, L.B. King, P.C. Sandel, J. Chung and R. Sater (2003) Positive and negative selection during B lymphocyte development. Immunol. Res. 27 427-442.
82. L. Morel, K.R. Blenman, B.P. Croker and E.K. Wakeland (2001) The major murine systemic lupus erythematosus susceptibility locus, Slel, is a cluster of functionally related genes. Proc. Natl. Acad. Sci. USA 98 1787-1792.
83. H Moriyama and G.S. Eisenbarth (2002) Genetics and environmental factors in endocrine/organ-specific autoimmunity: have there been any major advances? Springer Semin. Immunopathol. 24 231-242.
84. M.G. Netea, C. van der Graaf, J.W. Van der Meer and B.J. Kullberg (2004) Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J. Leukoc. Biol. 75 749-755.
85. J. Newman, J.S. Rice, C. Wang, S.L. Harris and B. Diamond (2003) Identification of an antigen-specific B cell population. J. Immunol. Methods 272 177-187.
86. A. Nobrega, B. Stransky, N. Nicolas and A. Coutinho (2002) Regeneration of natural antibody repertoire after massive ablation of lymphoid system: robust selection mechanism preserve antigen binding specificities. J. Immunol. 169 2971-2978.
87. J.K. Olson, J. Ludovic Croxford and S.D. Miller (2004) Innate and adaptive immune requirements for induction of autoimmune demyelinating disease by molecular mimicry. Mol. Immunol. 40 1103-1108.
88. B. O'Sullivan and R. Thomas (2003) CD40 and dendritic cell function. Crit. Rev. Immunol. 23 83-107.
89. M.E. Pauza, C.M. Dobbs, J. He, T. Patterson, S. Wagner, B.S. Anobile, B.J. Bradley, D. Lo and K. Haskins (2004) T-cell receptor transgenic response to an endogenous polymorphic autoantigen determines susceptibility to diabetes. Diabetes 53 978-988.
90. M.P. Pender (2003) Infection of autoreactive B lymphocytes with EBV causing chronic autoimmune diseases. Trends Immunol. 24 584-588.
91. C.J. Peutz-Kootstra, E. de Heer, P.J. Hoedemaeker, C.K. Abrass and J.A. Bruijn (2001) Lupus nephritis: lessons from experimental animal models. J. Lab. Clin. Med. 137 244-260.
92. J. Pitkanen and P. Peterson (2003) Autoimmune regulator: from loss of function to autoimmunity. Genes Immun. 4 12-21.
93. L.D. Poulton and A.G. Baxter (2001) Clinical application of NKT cell assays to the prediction of type 1 diabetes. Diabetes Metab. Res. Rev. 17 429-435.
94. S. Prahalad, E.S. Shear, S.D. Thompson, E.H. Giannini and D.N. Glass (2002) Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis. Arthritis Rheum. 46 1851-1856.
95. E.J. Price and P.J. Venables (1995) Drug-induced lupus. Drug Saf. 12 283-290.
96. P. Rahman, S. Bartlett, F. Siannis, F.J. Pellet, V.T. Farewell, L. Peddle, C.T. Schentag, C.A. Alderdice, S. Hamilton, M. Khraishi, Y. Tobin, D. Hefferton and D.D. Gladman (2003) CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am. J. Hum. Genet. 73 677-681.
97. K. Rajewsky (1996) Clonal selection and learning in the antibody system. Nature 381 751-758.
98. J.V. Ravetch and S. Bolland (2001) IgG Fe receptors. Annu. Rev. Immunol. 19 275-290.
99. C.T. Ravirajan and D.A. Isenberg (2002) Transgenic models of tolerance and autoimmunity: with special reference to systemic lupus erythematosus. Lupus 11 843-849.
100. J. Reddy, E. Bettelli, L. Nicholson, H. Waldner, M.H. Jang, K.W. Wucherpfennig and V.K. Kuchroo (2003) Detection of autoreactive myelin proteolipid protein 139–151-specific T cells by using MHC II (IAs) tetramers. J. Immunol. 170 870-877.
101. H. Reijonen, W.W. Kwok and G.T. Nepom (2003) Detection of CD4+ autoreactive T cells in T1D using HLA class II tetramers. Ann. N. Y. Acad. Sci. 1005 82-87.
102. W.M. Ridgway, M. Fasso, A. Lanctot, C. Garvey and C.G. Fathman (1996) Breaking self-tolerance in nonobese diabetic mice. J. Exp. Med. 183 1657-1662.
103. M.G. Roncarolo, R. Bacchetta, C. Bordignon, S. Narula and M.K. Levings (2001) Type 1 T regulatory cells. Immunol. Rev. 182 68-79.
104. E.F. Rosloniec, K. Latham and Y.B. Guedez (2002) Paradoxical roles of IFN-gamma in models of Th1-mediated autoimmunity. Arthritis Res. 4 333-336.
105. R.K. Russell, E.R. Nimmo and J. Satsangi (2004) Molecular genetics of Crohn's disease. Curr. Opin. Genet. Dev. 14 264-270.
106. S. Sakaguchi (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22 531-562.
107. A. Samuelsson, T.L. Towers and J.V. Ravetch (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291 484-486.
108. L. Schiffer, J. Sinha, X. Wang and A. Davidson (2002) SLE Therapeutics Meeting Washington, DC
109. E.E. Sercarz, P.V. Lehmann, A. Ametani, G. Benichou, A. Miller and K. Moudgil (1993) Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11 729-766.
110. E.A. Shamim and F.W. Miller (2000) Familial autoimmunity and the idiopathic inflammatory myopathies. Curr. Rheumatol. Rep. 2 201-211.
111. M.J. Shlomchik, J.E. Craft and M.J. Mamula (2001) From T to B and back again: positive feedback in systemic autoimmune disease. Nat. Rev. Immunol. 1 1470153.
112. V.D. Steen (1999) Occupational scleroderma. Curr. Opin. Rheumatol. 11 490-494.
113. R.M. Steinman, D. Hawiger and M.C. Nussenzeig (2003) Tolerogenic dendritic cells. Annu. Rev. Immunol. 21 685-711.
114. C.P. Strassburg, A. Vogel and M.P. Manns (2003) Autoimmunity and hepatitis C. Autoimmun. Rev. 2 322-331.
115. K. Sugimoto, S. Morimoto, H. Kaneko, K. Nozawa, Y. Tokano, Y. Takasaki and H. Hashimoto (2002) Decreased IL-4 producing CD4+T cells in patients with active systemic lupus erythematosus relation to IL-12R expression. Autoimmunity 35 381-387.
116. A. Suzuki, R. Yamada, X. Chang, S. Tokuhiro, T. Sawada, M. Suzuki, M. Nagasaki, M. Nakayama-Hamada, R. Kawaida, M. Ono, M. Ohtsuki, H. Furukuwa, S. Yoshino, M. Yokioka, S. Tohama, T. Matsubara, S. Wakitani, R. Teshima, Y. Nishioka, A. Sekine, A. Iida, A. Takahashi, T. Tsunoda, Y. Nakamura and K. Yamamota (2003) Functional haplotypes of PAD14, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34 395-402.
117. S.L. Swain (2003) Regulation of the generation and maintenance of T-cell memory: a direct, default pathway from effectors to memory cells. Microbes. Infect. 5 213-219.
118. S.J. Szabo, B.M. Sullivan, S.L. Peng and L.H. Glimcher (2003) Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21 713-758.
119. Q. Tang, K.I. Henriksen, E.B. Finger, G. Szot, J. Ye, E.L. Masteller, H. McDevitt, M. Bonyhadi and J.A. Bluestone (2004) In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199 1455-1465.
120. K.V. Tarbell, S. Yamazaki, K. Olson, P. Toy and R.M. Steinman (2004) CD25+CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199 1467-1477.
121. R.M. Tarzi and H.T. Cook (2003) Role of Fegamma receptors in glomerulonephritis. Nephron Exp. Nephrol. 95 7-12.
122. I.P. Tomlinson and W.F. Bodmer (1995) The HLA system and the analysis of multifactorial genetic disease. Trends Genet. 11 493-498.
123. B.P. Tsao (2003) The genetics of human systemic lupus erythematosus. Trends Immunol. 24 595-602.
124. H. Ueda, J.M. Howson, L. Esposito, J. Heward, H. Snook, G. Chamberlain, D.B. Rainbow, K.M. Hunter, A.N. Smith, G. Di Genova, M.H. Herr, I. Dhalman, F. Payne, D. Smyth, C. Lowe, R.C. Twells, S. Howlett, B. Healy, S. Nutland, H.E. Rance, V. Everett, L.J. Smink, A.C. Lam, H.J. Cordell, N.M. Walker, C. Bordin, J. Hulme, C. Motzo, F. Cucca, J.F. Hess, M.L. Metzker, J. Rogers, S. Gregory, A. Allahabadia, R. Nithiyananthan, E. Tuomilehto-Wolf, J. Tuomilehto, P. Bingley, K.M. Gillespie, D.E. Undlien, K.S. Ronningen, C. Guja, C. lonescu-Tirgoviste, D.A. Savage, A.P. Maxwell, D.J. Carson, C.C. Patterson, J.A. Franklyn, D.G. Clayton, L.B. Peterson, L.S. Wicker, J.A. Todd and S.C. Gough (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 506-511.
125. A.N. Vallejo, E. Davila, C.M. Weyand and J.J. Goronzy (2004) Biology of T lymphocytes. Rheum. Dis. Clin. North Am. 30 135-157.
126. T.C. van der Pouw Kraan, F.A. van Gaalen, T.W. Huizinga, E. Pieterman, F.C. Breedveld and C.L. Verweij (2003) Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair. Genes Immun. 4 187-196.
127. R. Varela-Calvino and M. Peakman (2003) Enteroviruses and type 1 diabetes. Diabetes Metab. Res. Rev. 19 431-441.
128. V. Vezys and L. Lefrancois (2002) Cutting edge: inflammatory signals drive organ-specific autoimmunity to normally cross-tolerizing endogenous antigen. J. Immunol. 169 6677-6680.
129. E.K. Wakeland, K. Liu, R.R. Graham and T.W. Behrens (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15 397-408.
130. L.S. Walker and A.K. Abbas (2002) The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2 11-19.
131. B. Wang, Y.B. Geng and C.R. Wang (2001) CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med. 194 313-320.
132. H.L. Weiner (2001) Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes. Infect. 3 947-954.
133. H. Wekerle and R. Hohlfeld (2003) Molecular mimicry in multiple sclerosis. N. Engl. J. Med. 349 185-186.
134. R.M. Welsh, L.K. Selin and E. Szomolanyi-Tsuda (2004) Immunological memory to viral infections. Annu. Rev. Immunol. 22 711-743.
135. G. Werlen, B. Hausmann, D. Naeher and E. Palmer (2003) Signaling life and death in the thymus: timing is everything. Science 299 1859-1863.
136. R. Winchester (2004) The genetics of autoimmune-mediated rheumatic diseases: clinical and biologic implication. Rheum. Dis. Clin. North Am. 30 213-227.
137. R. Winchester (2004) The genetics of autoimmune-mediated rheumatic diseases: clinical and biologic implication. Rheum. Dis. Clin. North Am. 30 viii.
138. F.S. Wong and L. Wen (2003) The study of HLA class II and autoimmune diabetes. Curr. Mol. Med. 3 1-15.
139. P.H. Wooley (2004) The usefulness and the limitations of animal models in identifying targets for therapy in arthritis. Best Pract. Res. Clin. Rheumatol. 18 47-58.
140. O. Wurtz, M. Bajenoff and S. Guerder (2004) IL-4-mediated inhibition of IFN-gamma production by CD4+ T cells proceeds by several developmentally regulated mechanisms. Int. Immunol. 16 501-508.
141. J. Yan and M.J. Mamula (2002) Autoreactive T cells revealed in the normal repertoire: escape from negative selection and peripheral tolerance. J. Immunol. 168 3188-3194.